Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gattex Goes To Advisory Panel With Positive Confirmatory Trial Data

Aug 22 2012

• By Cathy Dombrowski

Related Content

Takeda's $13.6 Bil. Nycomed Buy Meets Multiple Strategic, Financial Imperatives

May 23 2011

NPS Estimates Gattex Initial Market At $150 Million To $250 Million

Oct 11 2007

EU's CHMP Gives Green Light To Three New Products And A New Indication For Afinitor

Jun 22 2012

Swiss Pharma Nycomed Agrees To Market NPS’ Gattex Ex-U.S.

Oct 31 2007

Related Companies

NPS Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Amgen, Inc.

Additional Topics

Advisory Committees BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window